Variant:
rs59421388 at chr22:42523610 in CYP2D6 (VIP)

Alleles (on + chromosomal strand)
C > T
Amino Acid Translation
Val338Met
Alternate Names:
3271G>A, CYP2D6: 3183G>A, c.1012G>A, c.859G>A, g.21914179C>T, g.27909G>A, g.3330G>A, g.8274G>A, p.Val287Met, p.Val338Met

VIP Variant in CYP2D6

CYP2D6 3183G>A (also seen as 3271G>A in the literature) was first identified by Marez et al [Article:9241659] in a screening of a large European population. Although it is very rare in Europeans, it was later identified as part of the reduced functioning haplotype CYP2D6*29, which is found at an estimated allele frequency of 20% in African Tanzanians [Article:11470994]. Functional characterization of CYP2D6 3183G>A in COS-1 cells showed a slightly reduced activity as measured by bufuralol hydroxylation, but this activity was reduced further when the CYP2D6*29 mutations were made in combination [Article:11407994].

Note: The CYP2D6 gene is found on the minus chromosomal strand. Please note that for standardization, the PharmGKB presents all allele base pairs on the positive chromosomal strand, therefore the alleles within our variant annotations will differ (in a complementary manner) from those in this VIP summary that are given on the minus strand as reported in the literature.

Key Publications:
Drugs / Other Molecules
Diseases Cystic Fibrosis Depression Hypertension Neoplasms Pain Parkinson Disease Schizophrenia
Phenotype Datasets Hot flashes in tamoxifen patients
Lipid measurements in tamoxifen study
Lipid measurements in tamoxifen study - set 2
Meperidine N-demethylation by human CYP450 isoforms
Metabolism of yohimbine by human CYP450 isoforms
Patient responses to tamoxifen
Pharmacokinetics of Tamoxifen at 4 months
Thyroid binding globulin in tamoxifen patients

Appendix

CYP2D6: 3183G>A

Genomic Variant & GenBank ID: G4803A on M33388
mRNA Variant & GenBank ID: G1012A on X08006
Protein Variant & GenBank ID: V338M on AAH75024
GoldenPath Position: chr22:40853554 on hg 18
DNA Source Containing
*Homozygous Reference*
*Allele(Coriell Lines):*
GM17242
DNA Source Containing
*Heterozygous*
*Reference*
*Allele* (Coriell Lines):
GM17140
DNA Source Containing
*Homozygous Minor*
*Allele(Coriell Lines):*
GM17131

Connected Drugs

Connected Diseases

Publications related to rs59421388 at chr22:42523610: 2

No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activity. Pharmacogenetics. 2001. Wennerholm A, et al. [Article:11470994@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. Pharmacogenetics. 1997. Marez D, et al. [Article:9241659@PubMed]

Cross-References

UCSC Golden Path:
chr22:42523610
dbSNP:
rs59421388
ALFRED:
SI015499C

Common Searches

PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (R24 GM61374).
©2001-2012 PharmGKB.